Navigation Links
Varian Medical Systems Has Received CE Mark for Proton Therapy System
Date:2/19/2009

PALO ALTO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced that it has received CE mark for the Varian Proton Therapy System, which is designed to help doctors to improve treatments and outcomes in many cancer cases. With proton therapy, doctors can use higher doses of radiation to control and manage tumors while significantly reducing damage to healthy tissue and vital organs.

"CE mark is an important milestone in Varian's initiative to develop and market a compact system capable of intensity-modulated proton therapy in single- or multi-room facilities," said Lester Boeh, vice president of emerging businesses for the company. "This is a clear demonstration of our ongoing commitment to provide the cancer treatment community and its patients with a clinically practical and commercially viable proton therapy system that meets accepted safety standards for medical equipment."

The CE mark makes it possible for cancer treatment centers to begin ordering, installing, and using the Varian Proton Therapy System in regions where CE mark is required without having to obtain a site-specific clearance to use this important technology. "Varian is actively marketing the Varian Proton Therapy System, and institutions from all parts of the world are pursuing this promising technology for cancer patients in their regions," Boeh said.

Through research and development and the acquisition of ACCEL in Germany during 2007, Varian has developed a comprehensive proton therapy system that utilizes the company's technology for particle beam generation, treatment planning, imaging, motion management, and information management technology.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X- ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 60 sales and support offices around the world. For more information, visit http://www.varian.com.

FOR INFORMATION CONTACT:

Spencer Sias (650) 424-5782

spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
2. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
3. Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.
4. Fertility Drugs Do Not Increase Ovarian Cancer Risk
5. Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
6. Top Belgian Cancer Center Becomes First in Country to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009
8. Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbotts Architect(R) Analyzers
9. Gene Variant Raises Risk for Brain Cancer at Young Age
10. Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery
11. A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... ... 2017 , ... While it’s often important to take certain medications during the ... Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL ... it eliminates the need to turn on a light when taking medication during the ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated stainless ... FDA requirements, which stipulates new criteria regarding medical device manufacture and ... ID jewelry such as Medical ID Bracelets, can rest assured that ... the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process with ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
Breaking Medicine Technology: